Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-033619
Filing Date
2025-11-06
Accepted
2025-11-06 16:28:53
Documents
62
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q eton20250930_10q.htm   iXBRL 10-Q 1132768
2 EXHIBIT 31.1 ex_854687.htm EX-31.1 8730
3 EXHIBIT 31.2 ex_854688.htm EX-31.2 8730
4 EXHIBIT 32.1 ex_854689.htm EX-32.1 6338
  Complete submission text file 0001437749-25-033619.txt   6151674

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA eton-20250930.xsd EX-101.SCH 53005
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eton-20250930_cal.xml EX-101.CAL 34125
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eton-20250930_def.xml EX-101.DEF 409406
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE eton-20250930_lab.xml EX-101.LAB 368128
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eton-20250930_pre.xml EX-101.PRE 435293
65 EXTRACTED XBRL INSTANCE DOCUMENT eton20250930_10q_htm.xml XML 869871
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

EIN.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38738 | Film No.: 251458875
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)